1. Coronavirus disease (COVID-19) – World Health Organization . Who.int. https://www.who.int/emergencies/diseases/novel-coronavirus-2019. Accessed April 25, 2021.
Google Scholar2. Selvaraj, V, Herman, K, Dapaah-Afriyie, K. Severe, symptomatic reinfection in a patient with COVID-19. R I Med J (2013). 2020; 103(10):24–26.
Google Scholar | Medline3. Eisen, DP. Mannose-binding lectin deficiency and respiratory tract infection. J Innate Immun. 2010; 2(2):114–122.
Google Scholar | Crossref | Medline4. Mathur, G, Mathur, S. Antibody testing for COVID-19. Am J Clin Pathol. 2020; 154(1):1–3.
Google Scholar | Crossref | Medline5. Liu, X, Wang, J, Xu, X, Liao, G, Chen, Y, Hu, C-H. Patterns of IgG and IgM antibody response in COVID-19 patients. Emerg Microbes Infect. 2020; 9(1):1269–1274.
Google Scholar | Crossref | Medline6. Malfertheiner, S, Brandstetter, S, Roth, S, et al. Immune response to SARS-CoV-2 in health care workers following a COVID-19 outbreak: a prospective longitudinal study. J Clin Virol. 2020; 130:104575.
Google Scholar | Crossref | Medline7. Ip, WKE, Chan, KH, Law, HKW, et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis. 2005; 191(10):1697–1704.
Google Scholar | Crossref | Medline8. Magro, C, Mulvey, JJ, Berlin, D, et al. Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: a report of five cases. Transl Res. 2020; 220:1–13.
Google Scholar | Crossref | Medline9. Ling, MT, Tu, W, Han, Y, et al. Mannose-binding lectin contributes to deleterious inflammatory response in pandemic H1N1 and avian H9N2 infection. J Infect Dis. 2012; 205(1):44–53.
Google Scholar | Crossref | Medline10. To, KK-W, Hung, IF-N, Ip, JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing [published online ahead of print 2020]. Clin Infect Dis. doi:10.1093/cid/ciaa1275
Google Scholar11. Hansen, CH, Michlmayr, D, Gubbels, SM, Mølbak, K, Ethelberg, S. Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study. Lancet. 2021; 397(10280):1204–1212.
Google Scholar | Crossref | Medline